{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:08:45Z","timestamp":1793210925545,"version":"4.5.0"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T00:00:00Z","timestamp":1358467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00109-013-0993-5","type":"journal-article","created":{"date-parts":[[2013,1,17]],"date-time":"2013-01-17T03:52:42Z","timestamp":1358394762000},"page":"311-321","source":"Crossref","is-referenced-by-count":351,"title":["Ocular neovascularization"],"prefix":"10.1007","volume":"91","author":[{"given":"Peter A.","family":"Campochiaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,18]]},"reference":[{"key":"993_CR1","first-page":"137","volume":"68","author":"I Michaelson","year":"1948","unstructured":"Michaelson I (1948) The mode of development of the vascular system of the retina with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 68:137\u2013180","journal-title":"Trans Ophthalmol Soc UK"},{"key":"993_CR2","doi-asserted-by":"crossref","first-page":"7855","DOI":"10.1021\/bi00348a001","volume":"24","author":"A Baird","year":"1985","unstructured":"Baird A, Esch F, Gospodarowicz D, Guillemin R (1985) Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors. Biochemistry 24:7855\u20137860","journal-title":"Biochemistry"},{"key":"993_CR3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","volume":"359","author":"D Shweiki","year":"1992","unstructured":"Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843\u2013845","journal-title":"Nature"},{"key":"993_CR4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/359845a0","volume":"359","author":"KH Plate","year":"1992","unstructured":"Plate KH, Breier G, Welch HA, Risau W (1992) Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359:845\u2013848","journal-title":"Nature"},{"key":"993_CR5","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480\u20131487","journal-title":"N Engl J Med"},{"key":"993_CR6","first-page":"940","volume":"66","author":"A Patz","year":"1968","unstructured":"Patz A (1968) The role of oxygen in retrolental fibroplasia. Trans Am Opthalmol Soc 66:940\u2013985","journal-title":"Trans Am Opthalmol Soc"},{"key":"993_CR7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/02713688408997197","volume":"3","author":"A Patz","year":"1984","unstructured":"Patz A (1984) Current concepts of the effect of oxygen on the developing retina. Curr Eye Res 3:159\u2013163","journal-title":"Curr Eye Res"},{"key":"993_CR8","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/0002-9394(53)91779-6","volume":"36","author":"A Patz","year":"1953","unstructured":"Patz A, Eastham A, Higgenbotham DH, Kleh T (1953) Oxygen studies in retrolental figroplasia: production of the microscopic changes of retrolental fibroplasia in experimental animals. Am J Ophthalmol 36:1511\u20131522","journal-title":"Am J Ophthalmol"},{"key":"993_CR9","first-page":"101","volume":"35","author":"LEH Smith","year":"1994","unstructured":"Smith LEH, Wesolowski E, McLellan A, Kostyk SK, D\u2019Amato R, Sullivan R, D\u2019Amore PA (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101\u2013111","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR10","doi-asserted-by":"crossref","first-page":"10457","DOI":"10.1073\/pnas.92.23.10457","volume":"92","author":"LP Aiello","year":"1995","unstructured":"Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LEH (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457\u201310461","journal-title":"Proc Natl Acad Sci USA"},{"key":"993_CR11","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","volume":"1","author":"T Alon","year":"1995","unstructured":"Alon T, Hemo I, Itin A, Pe\u2019er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med 1:1024\u20131028","journal-title":"Nature Med"},{"key":"993_CR12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1001\/archopht.1996.01100140419009","volume":"114","author":"EA Pierce","year":"1996","unstructured":"Pierce EA, Foley ED, Smith LE (1996) Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch Ophthalmol 114:1219\u20131228","journal-title":"Arch Ophthalmol"},{"key":"993_CR13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","volume":"92","author":"EA Pierce","year":"1995","unstructured":"Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LEH (1995) Vascular endothelial growth factor\/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905\u2013909","journal-title":"Proc Natl Acad Sci USA"},{"key":"993_CR14","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.1073\/pnas.90.9.4304","volume":"90","author":"GL Wang","year":"1993","unstructured":"Wang GL, Semenza GL (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 90:4304\u20134308","journal-title":"Proc Natl Acad Sci USA"},{"key":"993_CR15","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang B-H, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510\u20135514","journal-title":"Proc Natl Acad Sci USA"},{"key":"993_CR16","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1152\/jappl.2000.88.4.1474","volume":"88","author":"GL Semenza","year":"2000","unstructured":"Semenza GL (2000) HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 88:1474\u20131480","journal-title":"J Appl Physiol"},{"key":"993_CR17","first-page":"182","volume":"40","author":"H Ozaki","year":"1999","unstructured":"Ozaki H, Yu A, Della N, Ozaki K, Luna JD, Yamada H, Hackett SF, Okamoto N, Zack DJ, Semenza GL et al (1999) Hypoxia inducible factor-1\u03b1 is increased in ischemic retina: temporal and spatial correlation with VEGF expression. Invest Ophthalmol Vis Sci 40:182\u2013189","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","volume":"93","author":"BD Kelly","year":"2003","unstructured":"Kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, Berg-Dixon S, Rowan A, Yan Z, Campochiaro PA, Semenza GL (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93:1074\u20131081","journal-title":"Circ Res"},{"key":"993_CR19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","volume":"7","author":"P Carmeliet","year":"2001","unstructured":"Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H et al (2001) Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7:575\u2013583","journal-title":"Nat Med"},{"key":"993_CR20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0002-9440(10)64612-3","volume":"157","author":"M-S Seo","year":"2000","unstructured":"Seo M-S, Okamoto N, Vinores MA, Vinores SA, Hackett SF, Yamada H, Yamada E, Derevjanik NL, LaRochelle W, Zack DJ et al (2000) Photoreceptor-specific expression of PDGF-B results in traction retinal detachment. Am J Pathol 157:995\u20131005","journal-title":"Am J Pathol"},{"key":"993_CR21","first-page":"2001","volume":"43","author":"K Mori","year":"2002","unstructured":"Mori K, Gehlbach P, Ando A, Dyer G, Lipinsky E, Chaudhry AG, Hackett SF, Campochiaro PA (2002) Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. Invest Ophthalmol Vis Sci 43:2001\u20132006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR22","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1096\/fj.06-7359com","volume":"21","author":"R Lima e Silva","year":"2007","unstructured":"Lima e Silva R, Shen J, Hackett SF, Kachi S, Akiyama H, Kiuchi K, Yokoi K, Hatara C, McLauer T, Aslam S (2007) The SDF-1\/CXCR4 ligand\/receptor pair is an important contributor to several types of ocular neovascularization. FASEB J 21:3219\u20133230","journal-title":"FASEB J"},{"key":"993_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2006.09.009","volume":"313","author":"H Diez","year":"2007","unstructured":"Diez H, Fischer A, Winkler A, Hu C-J, Hatzopoulos AK, Breier G, Gessler M (2007) Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate. Exp Cell Res 313:1\u20139","journal-title":"Exp Cell Res"},{"key":"993_CR24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.modgep.2006.11.002","volume":"7","author":"JJ Hofmann","year":"2007","unstructured":"Hofmann JJ, Iruela-Arispe ML (2007) Notch expression patterns in the retina: an eye on receptor\u2013ligand distribution during angiogenesis. Gene Expr Patterns 7:461\u2013470","journal-title":"Gene Expr Patterns"},{"key":"993_CR25","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature05571","volume":"15","author":"M Hellstrom","year":"2007","unstructured":"Hellstrom M, Phing LK, Hofmman JJ, Wallgard E, Coultas L, Lindblom P, Alva J, Nilsson AK, Karlsson L, Gaiano N et al (2007) Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 15:776\u2013780","journal-title":"Nature"},{"key":"993_CR26","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2009.03.025","volume":"137","author":"R Benedito","year":"2009","unstructured":"Benedito R, Roca C, Sorensen I, Adams S, Gossler A, Fruttiger M, Adams RH (2009) The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137:1124\u20131135","journal-title":"Cell"},{"key":"993_CR27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature03875","volume":"436","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P, Tessier-Lavigne M (2005) Common mechanisms of nerve and blood vessel wiring. Nature 436:193\u2013200","journal-title":"Nature"},{"key":"993_CR28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00006982-200110000-00003","volume":"21","author":"LA Yannuzzi","year":"2001","unstructured":"Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter JS, Freund KB, Sorenson J, Orlock D, Borodoker N (2001) Retinal angiomatous proliferation in age-related macular degeneration. Retina 21:416\u2013434","journal-title":"Retina"},{"key":"993_CR29","first-page":"281","volume":"151","author":"N Okamoto","year":"1997","unstructured":"Okamoto N, Tobe T, Hackett SF, Ozaki H, Vinores MA, LaRochelle W, Zack DJ, Campochiaro PA (1997) Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 151:281\u2013291","journal-title":"Am J Pathol"},{"key":"993_CR30","first-page":"180","volume":"39","author":"T Tobe","year":"1998","unstructured":"Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA (1998) Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Invest Ophthalmol Vis Sci 39:180\u2013188","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR31","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00006982-200308000-00012","volume":"23","author":"JR Heckenlively","year":"2003","unstructured":"Heckenlively JR, Hawes NL, Friedlander M, Nusinowitz S, Hurd R, Davisson M, Chang B (2003) Mouse model of subretinal neovascularization with choroidal anastomosis. Retina 23:518\u2013522","journal-title":"Retina"},{"key":"993_CR32","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/archopht.125.6.795","volume":"125","author":"C Li","year":"2007","unstructured":"Li C, Huang Z, Kingsley R, Zhou X, Li F, Parke DW 2nd, Cao W (2007) Biochemical alterations in the retinas of very low-density lipoprotein receptor knockout mice: an animal model of retinal angiomatous proliferation. Arch Ophthalmol 125:795\u2013803","journal-title":"Arch Ophthalmol"},{"key":"993_CR33","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1097-4652(200010)185:1<135::AID-JCP13>3.0.CO;2-Y","volume":"185","author":"H Yamada","year":"2000","unstructured":"Yamada H, Yamada E, Kwak N, Ando A, Suzuki A, Esumi N, Zack DJ, Campochiaro PA (2000) Cell injury unmasks a latent proangiogenic phenotype in mice with increased expression of FGF2 in the retina. J Cell Physiol 185:135\u2013142","journal-title":"J Cell Physiol"},{"key":"993_CR34","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1001\/archopht.1982.01030040784015","volume":"100","author":"SJ Ryan","year":"1982","unstructured":"Ryan SJ (1982) Subretinal neovascularization: natural history of an experimental model. Arch Ophthalmol 100:1804\u20131809","journal-title":"Arch Ophthalmol"},{"key":"993_CR35","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65753-7","volume":"153","author":"T Tobe","year":"1998","unstructured":"Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjanik NL, Vinores SA, Basilico C, Campochiaro PA (1998) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153:1641\u20131646","journal-title":"Am J Pathol"},{"key":"993_CR36","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1096\/fj.04-2209fje","volume":"19","author":"Y Oshima","year":"2005","unstructured":"Oshima Y, Oshima S, Nambu H, Kachi S, Takahashi K, Umeda N, Shen J, Dong A, Apte RS, Duh E et al (2005) Different effects of angiopoietin 2 in different vascular beds in the eye; new vessels are most sensitive. FASEB J 19:963\u2013965","journal-title":"FASEB J"},{"key":"993_CR37","first-page":"3158","volume":"41","author":"N Kwak","year":"2000","unstructured":"Kwak N, Okamoto N, Wood JM, Campochiaro PA (2000) VEGF is an important stimulator in a model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41:3158\u20133164","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","volume":"120","author":"MG Kryzstolik","year":"2002","unstructured":"Kryzstolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NM, Li W, Connolly E, O\u2019Neill CA, Miller JW (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338\u2013346","journal-title":"Arch Ophthalmol"},{"key":"993_CR39","first-page":"3582","volume":"41","author":"J Baffi","year":"2000","unstructured":"Baffi J, Byrnes G, Chan CC, Csaky KG (2000) Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. Invest Ophthalmol Vis Sci 41:3582\u20133589","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR40","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jcp.20110","volume":"201","author":"Y Oshima","year":"2004","unstructured":"Oshima Y, Oshima S, Nambu H, Kachi S, Hackett SF, Melia M, Kaleko M, Connelly S, Esumi N, Zack DJ et al (2004) Increased expression of VEGF in retinal pigmented epithelial cells is not sufficient to cause choroidal neovascularization. J Cell Physiol 201:393\u2013400","journal-title":"J Cell Physiol"},{"key":"993_CR41","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jcp.20525","volume":"206","author":"SA Vinores","year":"2006","unstructured":"Vinores SA, Xiao WH, Aslam S, Shen J, Oshima Y, Nambu H, Liu H, Carmeliet P, Campochiaro PA (2006) Implication of the hypoxia response element of the VEGF promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol 206:749\u2013758","journal-title":"J Cell Physiol"},{"key":"993_CR42","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2353\/ajpath.2006.050588","volume":"168","author":"N Jo","year":"2006","unstructured":"Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT (2006) Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol 168:2036\u20132053","journal-title":"Am J Pathol"},{"key":"993_CR43","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.1073\/pnas.0809763105","volume":"105","author":"H Zhang","year":"2008","unstructured":"Zhang H, Qian DZ, Tan YS, Lee K, Gao P, Ren YR, Rey S, Hammers H, Chang D, Pili R et al (2008) Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci USA 105:19579\u201319586","journal-title":"Proc Natl Acad Sci USA"},{"key":"993_CR44","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1096\/fj.09-145664","volume":"24","author":"T Yoshida","year":"2010","unstructured":"Yoshida T, Zhang H, Iwase T, Shen J, Semenza G, Campochiaro PA (2010) Digoxin inhibits retinal ischemia-induced HIF-1\u03b1 expression and ocular neovascularization. FASEB J 24:1759\u20131767","journal-title":"FASEB J"},{"key":"993_CR45","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.95.20.11715","volume":"95","author":"NS Chandel","year":"1998","unstructured":"Chandel NS, Maltepe E, Godwasser E, Mathieu CE, Simon MC, Schumacker PT (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci U S A 95:11715\u201311720","journal-title":"Proc Natl Acad Sci U S A"},{"key":"993_CR46","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","volume":"275","author":"NS Chandel","year":"2000","unstructured":"Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM, Schumacker PT (2000) Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia. J Biol Chem 275:25130\u201321138","journal-title":"J Biol Chem"},{"key":"993_CR47","doi-asserted-by":"crossref","first-page":"41928","DOI":"10.1074\/jbc.M508718200","volume":"280","author":"H Lu","year":"2005","unstructured":"Lu H, Dalgard CL, Mohyeldin A, McGate T, Tait AS, Verma A (2005) Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J Biol Chem 280:41928\u201341939","journal-title":"J Biol Chem"},{"key":"993_CR48","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/jcp.21698","volume":"219","author":"A Dong","year":"2009","unstructured":"Dong A, Xie B, Shen J, Yoshida T, Yokoi K, Hackett SF, Campochiaro PA (2009) Oxidative stress promotes ocular neovascularization. J Cell Physiol 219:544\u2013552","journal-title":"J Cell Physiol"},{"key":"993_CR49","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","volume":"119","author":"Age-Related Eye Disease Study Research Group","year":"2001","unstructured":"Age-Related Eye Disease Study Research Group (2001) A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol 119:1417\u20131436","journal-title":"Arch Ophthalmol"},{"key":"993_CR50","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V87.8.3336.bloodjournal8783336","volume":"87","author":"B Barleon","year":"1996","unstructured":"Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336\u20133343","journal-title":"Blood"},{"key":"993_CR51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cell.2005.10.036","volume":"124","author":"M Grunewald","year":"2006","unstructured":"Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, Chimenti S, Landsman L, Abramaovitch R, Keshet E (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124:175\u2013189","journal-title":"Cell"},{"key":"993_CR52","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/8462","volume":"5","author":"T Takahashi","year":"1999","unstructured":"Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434\u2013438","journal-title":"Nat Med"},{"key":"993_CR53","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/nm744","volume":"8","author":"A Otani","year":"2002","unstructured":"Otani A, Kinder K, Ewait K, Otero FJ, Schimmel P, Friedlander M (2002) Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 8:1004\u20131010","journal-title":"Nat Med"},{"key":"993_CR54","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm0602-607","volume":"8","author":"MB Grant","year":"2002","unstructured":"Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, Mamee RN, Byrne BJ, Vaught T, Spoerri PE, Peck AB et al (2002) Adult hematopoietic stem cells provide functional hemangioblastic activity during retinal neovascularization. Nat Med 8:607\u2013612","journal-title":"Nat Med"},{"key":"993_CR55","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1167\/iovs.03-0342","volume":"44","author":"N Sengupta","year":"2003","unstructured":"Sengupta N, Calballero S, Mames RN, Butler JM, Scott EW, Grant MB (2003) The role of adult bone marrow-derived stem cells in choroidal neovascularization. Invest Ophthalmol Vis Sci 44:4908\u20134913","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0092-8674(93)80047-I","volume":"74","author":"RA Lang","year":"1993","unstructured":"Lang RA, Bishop MJ (1993) Macrophages are required for cell death and tissue remodeling in the developing mouse eye. Cell 74:453\u2013462","journal-title":"Cell"},{"key":"993_CR57","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature03928","volume":"437","author":"IB Lobov","year":"2005","unstructured":"Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, Ondr JK, Kurup S, Galss DA, Patel MS, Shu W et al (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437:417\u2013421","journal-title":"Nature"},{"key":"993_CR58","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1371\/journal.pmed.0030310","volume":"8","author":"RS Apte","year":"2006","unstructured":"Apte RS, Richter J, Herndon J, Ferguson TA (2006) Macrophage inhibition of neovascularization in a murine model of age-related macular degeneration. PLoS Med 8:e310","journal-title":"PLoS Med"},{"key":"993_CR59","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/ICO.0b013e3181930bcd","volume":"28","author":"P Lu","year":"2009","unstructured":"Lu P, Li L, LIu G, van Rooijen N, Mukaida N, Zhang X (2009) Opposite roles of CCR2 and CX3CR1 macrophages in alkali-induced corneal neovascularization. Cornea 28:562\u2013569","journal-title":"Cornea"},{"key":"993_CR60","doi-asserted-by":"crossref","first-page":"e1002671","DOI":"10.1371\/journal.ppat.1002671","volume":"8","author":"SW Cousins","year":"2012","unstructured":"Cousins SW, Esponosa-Heidmann DG, Miller DM, Pereira-Simon S, Hernandez EP, Chien H, Meier-jewett C, Dix RD (2012) Cytomegalovirus infection results in more severe experimental choroidal neovascularization. PLoS Pathog 8:e1002671","journal-title":"PLoS Pathog"},{"key":"993_CR61","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1167\/iovs.07-0113","volume":"48","author":"J Shen","year":"2007","unstructured":"Shen J, Xie B, Dong A, Swaim M, Hackett SF, Campochiaro PA (2007) In vivo immunostaining demonstrates macrophages associate with growing and regressing vessels. Invest Ophthalmol Vis Sci 48:4335\u20134341","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR62","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1182\/blood-2010-12-327015","volume":"118","author":"HH Outtz","year":"2011","unstructured":"Outtz HH, Tattersall IW, Kofler NM, Steinbach N, Kitajewski J (2011) Notch 1 controls macrophage recruitment and Notch signaling is activated at sites of endothelial cell anastomosis during retinal angiogenesis in mice. Blood 118:3436\u20133439","journal-title":"Blood"},{"key":"993_CR63","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nature10085","volume":"474","author":"JAR Stefater","year":"2011","unstructured":"Stefater JAR, Lewkowich I, Rao S, Mariggi G, Carpenter AC, Burr AR, Fan J, Ajima R, Molkentin JD, Willimas BO (2011) Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. Nature 474:511\u2013515","journal-title":"Nature"},{"key":"993_CR64","doi-asserted-by":"crossref","unstructured":"Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb Z, Banda MJ (1983) Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221: 1283\u20131285","DOI":"10.1126\/science.6612342"},{"key":"993_CR65","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1172\/JCI32430","volume":"117","author":"J Kelly","year":"2007","unstructured":"Kelly J, Khan AA, Yin J, Ferguson TA, Apte RS (2007) Senescence regulates macrophage activation and angiogenic fate at site of tissue injury in mice. J Clin Invest 117:3421\u20133426","journal-title":"J Clin Invest"},{"key":"993_CR66","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1167\/iovs.03-0038","volume":"44","author":"DG Espinosa-Heidmann","year":"2003","unstructured":"Espinosa-Heidmann DG, Suner IJ, Hernandez E, Monroy D, Csaky KG, Cousins SW (2003) Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44:3586\u20133592","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1189\/jlb.0902436","volume":"74","author":"C Tsutsumi","year":"2003","unstructured":"Tsutsumi C, Sonoda KH, Egashira K, Qiao H, Hisatomi T, Nakao S, Ishibashi M, Charo IF, Sakamoto T, Murata T et al (2003) The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization. J Leukoc Biol 74:25\u201332","journal-title":"J Leukoc Biol"},{"key":"993_CR68","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1096\/fj.07-105346","volume":"22","author":"K Noda","year":"2008","unstructured":"Noda K, She H, Nakazawa T, Hisatomi T, Nakao S, Almulki L, Zandi S, Miyahara S, Ito Y, Thomas KL et al (2008) Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. FASEB J 22:2928\u20132935","journal-title":"FASEB J"},{"key":"993_CR69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/jcp.21588","volume":"218","author":"B Xie","year":"2009","unstructured":"Xie B, Shen J, Dong A, Rashid A, Stoller G, Campochiaro PA (2009) Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization. J Cell Physiol 218:192\u2013198","journal-title":"J Cell Physiol"},{"key":"993_CR70","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20081605","volume":"206","author":"Y Kubota","year":"2009","unstructured":"Kubota Y, Takubo K, Shimizu T, Ohno H, Kishi K, Shibuya M, Saya H, Suda T (2009) M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis. J Exp Med 206:1089\u20131102","journal-title":"J Exp Med"},{"key":"993_CR71","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/376070a0","volume":"376","author":"TN Sato","year":"1995","unstructured":"Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70\u201374","journal-title":"Nature"},{"key":"993_CR72","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0092-8674(00)81812-7","volume":"87","author":"S Davis","year":"1996","unstructured":"Davis S, Aldrich TH, Jones P, Acheson A, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161\u20131169","journal-title":"Cell"},{"key":"993_CR73","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","volume":"277","author":"PC Maisonpierre","year":"1997","unstructured":"Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N et al (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55\u201360","journal-title":"Science"},{"key":"993_CR74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1097-4652(200009)184:3<275::AID-JCP1>3.0.CO;2-7","volume":"184","author":"SF Hackett","year":"2000","unstructured":"Hackett SF, Ozaki H, Strauss RW, Wahlin K, Suri C, Maisonpierre P, Yancopoulos G, Campochiaro PA (2000) Angiopoietin 2 expression in the retina: upregulation during physiologic and pathologic neovascularization. J Cell Physiol 184:275\u2013284","journal-title":"J Cell Physiol"},{"key":"993_CR75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jcp.10128","volume":"192","author":"SF Hackett","year":"2002","unstructured":"Hackett SF, Wiegand SJ, Yancopoulos G, Campochiaro P (2002) Angiopoietin-2 plays an important role in retinal angiogenesis. J Cell Physiol 192:182\u2013187","journal-title":"J Cell Physiol"},{"key":"993_CR76","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1534-5807(02)00217-4","volume":"3","author":"NW Gale","year":"2002","unstructured":"Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte M, Jackson D et al (2002) Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by angiopoietin-1. Devel Cell 3:411\u2013423","journal-title":"Devel Cell"},{"key":"993_CR77","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/jcp.10442","volume":"199","author":"Y Oshima","year":"2004","unstructured":"Oshima Y, Deering T, Oshima S, Nambu H, Reddy PS, Kaleko M, Connelly S, Hackett SF, Campochiaro PA (2004) Angiopoietin-2 enhances retinal vessel sensitivity to vascular endothelial growth factor. J Cell Physiol 199:412\u2013417","journal-title":"J Cell Physiol"},{"key":"993_CR78","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.gt.3302230","volume":"11","author":"H Nambu","year":"2004","unstructured":"Nambu H, Nambu R, Oshima Y, Hackett SF, Wiegand SJ, Yancopoulos G, Zack DJ, Campochiaro PA (2004) Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood-retinal barrier. Gene Ther 11:865\u2013873","journal-title":"Gene Ther"},{"key":"993_CR79","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcp.20292","volume":"204","author":"H Nambu","year":"2005","unstructured":"Nambu H, Umeda N, Kachi S, Oshima Y, Nambu R, Campochiaro PA (2005) Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization. J Cell Physiol 204:227\u2013235","journal-title":"J Cell Physiol"},{"key":"993_CR80","doi-asserted-by":"crossref","first-page":"9764","DOI":"10.1073\/pnas.93.18.9764","volume":"93","author":"M Friedlander","year":"1996","unstructured":"Friedlander M, Theesfeld CL, Sugita M, Fruttiger M, Thomas MA, Chang S, Cheresh DA (1996) Involvement of integrins alpha-v beta-3 and alpha-v beta-5 in ocular neovascular diseases. Proc Natl Acad Sci USA 93:9764\u20139769","journal-title":"Proc Natl Acad Sci USA"},{"key":"993_CR81","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nm0596-529","volume":"2","author":"H Hammes","year":"1996","unstructured":"Hammes H, Brownlee M, Jonczyk A, Sutter A, Preissner K (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 2:529\u2013533","journal-title":"Nat Med"},{"key":"993_CR82","first-page":"563","volume":"75","author":"J Luna","year":"1996","unstructured":"Luna J, Tobe T, Mousa SA, Reilly TM, Campochiaro PA (1996) Antagonists of integrin alpha-v beta-3 inhibit retinal neovascularization in a murine model. Lab Invest 75:563\u2013573","journal-title":"Lab Invest"},{"key":"993_CR83","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1124\/mol.105.020941","volume":"69","author":"N Umeda","year":"2006","unstructured":"Umeda N, Kachi S, Akiyama H, Zahn G, Vossmeyer D, Stragies R, Campochiaro PA (2006) Suppression and regression of choroidal neovascularization by systemic administration of an Alpha5Beta1 integrin antagonist. Mol Pharmacol 69:1820\u20131828","journal-title":"Mol Pharmacol"},{"key":"993_CR84","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birknead JR, Olsen BR, Folkman J (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277\u2013285","journal-title":"Cell"},{"key":"993_CR85","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1006\/bbrc.1999.0248","volume":"255","author":"R Ramchandran","year":"1999","unstructured":"Ramchandran R, Dhanabal M, Volk R, Waterman MJ, Segal M, Lu H, Knebelmann B, Sukhatme VP (1999) Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Comm 255:735\u2013739","journal-title":"Biochem Biophys Res Comm"},{"key":"993_CR86","first-page":"2520","volume":"60","author":"PC Colorado","year":"2000","unstructured":"Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK et al (2000) Anti-angiogenic cues from vascular basement membrane collagen. Canc Res 60:2520\u20132526","journal-title":"Canc Res"},{"key":"993_CR87","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","volume":"275","author":"GD Kamphaus","year":"2000","unstructured":"Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torres A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R (2000) Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 275:1209\u20131215","journal-title":"J Biol Chem"},{"key":"993_CR88","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1074\/jbc.275.11.8051","volume":"275","author":"C Petitclerc","year":"2000","unstructured":"Petitclerc C, Boutaud A, Prestayko A, Xu J, Sado Y, Ninomiya Y, Sarras MP Jr, Hudson BG, Brooks PC (2000) New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 275:8051\u20138061","journal-title":"J Biol Chem"},{"key":"993_CR89","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jcp.20645","volume":"208","author":"R Lima e Silva","year":"2006","unstructured":"Lima e Silva R, Kachi S, Akiyama H, Shen J, Aslam S, Gong YY, Khu NH, Hatara MC, Boutaud A, Peterson R et al (2006) Recombinant non-collagenous domain of \u03b12(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis. J Cell Physiol 208:161\u2013166","journal-title":"J Cell Physiol"},{"key":"993_CR90","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)61697-5","volume":"159","author":"K Mori","year":"2001","unstructured":"Mori K, Ando A, Gehlbach P, Nesbitt D, Takahashi K, Goldsteen D, Penn M, Chen CT, Melia M, Phipps S et al (2001) Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am J Pathol 159:313\u2013320","journal-title":"Am J Pathol"},{"key":"993_CR91","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1096\/fj.02-0824fje","volume":"17","author":"K Takahashi","year":"2003","unstructured":"Takahashi K, Saishin Y, Saishin Y, Lima Silva R, Oshima Y, Oshima S, Melia M, Paszkiet B, Zerby D, Kadan MJ et al (2003) Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment. FASEB J 17:896\u2013898","journal-title":"FASEB J"},{"key":"993_CR92","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcp.1114","volume":"188","author":"K Mori","year":"2001","unstructured":"Mori K, Duh E, Gehlbach P, Ando A, Takahashi K, Pearlman J, Mori K, Yang HS, Zack DJ, Ettyreddy D et al (2001) Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization. J Cell Physiol 188:253\u2013263","journal-title":"J Cell Physiol"},{"key":"993_CR93","first-page":"2401","volume":"42","author":"C-C Lai","year":"2001","unstructured":"Lai C-C, Wu W-C, Chen S-L, Xiao X, Tsai T-C, Huan S-J, Chen T-L, Tsai RJ-F, Tsao Y-P (2001) Suppression of choroidal neovascularization by adeno-associated virus vector expressing angiostatin. Invest Ophthalmol Vis Sci 42:2401\u20132407","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR94","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1089\/104303401750270959","volume":"12","author":"C-M Lai","year":"2001","unstructured":"Lai C-M, Brankov M, Zaknich T, Lai YK-Y, Shen W-Y, Constable IJ, Kovesdi I, Rakoczy PE (2001) Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization. Human Gene Ther 12:1299\u20131310","journal-title":"Human Gene Ther"},{"key":"993_CR95","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/sj.gt.3301695","volume":"9","author":"YK Lai","year":"2002","unstructured":"Lai YK, Shen WY, Brankov M, Lai CM, Constable IJ, Rakoczy PE (2002) Potential long-term inhibition of ocular neovascularization by recombinant adeno-associated virus-mediated secretion gene therapy. Gene Ther 9:804\u2013813","journal-title":"Gene Ther"},{"key":"993_CR96","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1096\/fj.05-5046fje","volume":"20","author":"J Shen","year":"2006","unstructured":"Shen J, Yang XR, Xiao WH, Hackett SF, Sato Y, Campochiaro PA (2006) Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization. FASEB J 20:723\u2013725","journal-title":"FASEB J"},{"key":"993_CR97","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/01.iae.0000242842.14624.e7","volume":"26","author":"N Ferrara","year":"2006","unstructured":"Ferrara N, Damico L, Shams N, Lowman H, Kim R (2006) Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26:859\u2013870","journal-title":"Retina"},{"key":"993_CR98","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1167\/iovs.04-0601","volume":"46","author":"J Gaudreault","year":"2005","unstructured":"Gaudreault J, Fei D, Rusit J, Suboc P, Shiu V (2005) Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci 46:726\u2013733","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"993_CR99","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, Group MS (2006) Ranibizumab for neovascular age-related macular degeneration. N Eng J Med 355:1419\u20131431","journal-title":"N Eng J Med"},{"key":"993_CR100","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","volume":"355","author":"DM Brown","year":"2006","unstructured":"Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY, Sy JP, Schneider S, Group AS (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Eng J Med 355:1432\u20131444","journal-title":"N Eng J Med"},{"key":"993_CR101","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jcp.10246","volume":"195","author":"Y Saishin","year":"2003","unstructured":"Saishin Y, Takahashi K, Lima Silva R, Hylton D, Rudge J, WS J, Campochiaro PA (2003) VEGF-TRAPR1R2 suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier. J Cell Physiol 195:241\u2013248","journal-title":"J Cell Physiol"},{"key":"993_CR102","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier JS, Brown DM, Chong V, Korobelnik JF, Kaiser PK, Nguyen QD, Kirchhof B, Ho A, Ogura Y, Yancopoulos GD et al (2012) Intravitreal Aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration. Ophthalmology 119:2537\u20132548","journal-title":"Ophthalmology"},{"key":"993_CR103","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","volume":"364","author":"DF Marin","year":"2011","unstructured":"CATT Research Group, Marin DF, Maguire MG, Ying GS, Grunwald JE, Fine SL, Jaffe GJ (2011) Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Eng J Med 364:1897\u20131908","journal-title":"N Eng J Med"},{"key":"993_CR104","unstructured":"Boyer DS, Ophthotech Anti-PDGF in AMD Study Group (2009) Combined inhibition of platelet-derived (PDGF) and vascular endothelial (VEGF) growth factors for the treatment of neovascular age-related macular degeneration (NV-AMD). Results of a phase 1 study. Invest Ophthalmol Vis Sci Online ARVO abstract 1260"},{"key":"993_CR105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/hum.2006.17.167","volume":"17","author":"PA Campochiaro","year":"2006","unstructured":"Campochiaro PA, Nguyen QD, Shah SM, Klein ML, Holz E, Frank RN, Saperstein DA, Gupta A, Stout JT, Macko J et al (2006) Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther 17:167\u2013176","journal-title":"Hum Gene Ther"},{"key":"993_CR106","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/hum.2011.050","volume":"22","author":"PA Campochiaro","year":"2011","unstructured":"Campochiaro PA (2011) Gene transfer for neovascular age-related macular degeneration. Hum Gene Ther 22:523\u2013529","journal-title":"Hum Gene Ther"},{"key":"993_CR107","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/gt.2011.164","volume":"19","author":"PA Campochiaro","year":"2012","unstructured":"Campochiaro PA (2012) Gene transfer for ocular neovascularization and macular edema. Gene Ther 19:121\u2013126","journal-title":"Gene Ther"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-013-0993-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-013-0993-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-013-0993-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T10:53:46Z","timestamp":1595242426000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-013-0993-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,18]]},"references-count":107,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["993"],"URL":"https:\/\/doi.org\/10.1007\/s00109-013-0993-5","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,18]]}}}